Page 60 - Roche Diagnostics News Today

The fourth edition of Dia:gram Media Forum explored the challenges and opportunities for diagnostics in the “new normal” in a virtual event, "The Journey to Better Care: Diagnostics Beyond Covid-19" on Wednesday.

Also: Papa moves into the employer market, and Lark Health is working on a heart health platform.

A Swiss-led research consortium has partnered with Basel-based biotech RocketVax to launch clinical trials for a nasal spray vaccine.

Global Cell Dissociation Market Growing with a CAGR of 13.1% during 2021-2027

Global Orthopedic Oncology Market: OverviewRising prevalence of musculoskeletal disorders are expected to drive the demand for effective treatment therapies for treatment of various cancers associated with bones and soft tissues. The orthopedic oncology market is expected to grow at a healthy pace attributed to risi...

Global Cell Dissociation Market Growing with a CAGR of 13.1% during 2021-2027

In the two years since it launched the world's first commercially available COVID-19 PCR test, Roche Diagnostics UK and Ireland has distributed ten million tests from its base in West Sussex.

Investegate announcements from F. Hoffmann-La Roche Ltd, Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern

Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and DeltaThe World

Soft sensors have the advantages of flexibility and versatility compared with fixed, dedicated sensors. Scientists at Roche Diagnostics have described a first-in-kind off-gas-based soft sensor for simultaneous, real-time monitoring of biomass and pyruvate metabolism in Chinese hamster ovary cultures. This model-derived approach trained the sensor through 14 technically similar CHO cultures in which processes differed only in terms of the CHO cell line.